First Diabetic Glucometer for the iPhone Now Available in Europe


Sanofi-Aventis and AgaMatrix are unveiling a device that combines an advanced glucometer with an iOS app that lets patients share data with providers.

This article originally appeared at, part of the HCPLive network.

Seemingly ages ago, in a 2009 Steve Jobs presentation unveiling the new features of iPhone OS 3.0 (before it was renamed iOS), a J&J company named Lifescan demonstrated a device that took advantage of Apple’s newly provided connectivity to the 30 pin dock connector.

The demonstration produced ripples of interest in the medical community since it was the first glimpse of how hardware and software could work together to extend smartphones into real medical devices that follow patients wherever they go. However, in an interview with Mobihealthnews, the company admitted that it was just a demonstration unit without a clear path to commercialization at that time.

Now, Sanofi-Aventis and AgaMatrix have unveiled a commercial device that combines an advanced glucometer with an iOS app that shares glucose data with patients’ providers. As Medgadget reported, the product still requires 510(k) approval before being deployed as a medical device. At this time, it is not clear when this might occur.

To read the entire article, click here.

Related Videos
Alexandra Louise Møller, MS, PhD | Credit: LinkedIn
A panel of 5 experts on Cushing's syndrome
A panel of 5 experts on Cushing's syndrome
Optimizing Diabetes Therapies with New Classifications
Vlado Perkovic, MBBS, PhD | Credit: George Institute of Global Health
Should We Reclassify Diabetes Subtypes?
Tailoring Chest Pain Diagnostics to Patients, with Kyle Fortman, PA-C, MBA
Solutions to Prevent Climate Change-Related Illness, with Janelle Bludhorn, PA-C
Kyle Fortman, PA-C, MBA: Troponin and Heart Injury Risk Screening Recommendations
What Should the American Academy of Physician Associates Focus on in 2025?
© 2024 MJH Life Sciences

All rights reserved.